GlassScriptPhysician profile
Todd C Bramlee
NPI 1851650477
$5,474.16
in general payments reported to CMS, 2019-2025
38 companies · $70.66 in 2025
The $70.66 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $1,041 · 2021: $959 · 2022: $1,106 · 2023: $1,347 · 2024: $557 · 2025: $70.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,974.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,974.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,204.61 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $912.63 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $417.53 | 2019-2024 | |
| Abbott Laboratories | $410.17 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $254.44 | 2019-2023 | Xarelto |
| Amgen INC. | $238.61 | 2019-2023 | Repatha |
| Glaxosmithkline, LLC. | $231.54 | 2020-2024 | Shingrix, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $219.32 | 2019-2024 | Farxiga |
| Amarin Pharma, INC. | $214.78 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.87 | 2021-2024 | Jardiance |
| Exact Sciences Corporation | $136.69 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $102.66 | 2019-2024 | Mounjaro, Jardiance, Emgality |
| Takeda Pharmaceuticals U.S.A., INC. | $100.05 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $88.29 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.62 | 2019-2023 | Xifaxan |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Bramlee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.